Poland· PL-100013399
Cefobid
A cefoperazone product containing cefoperazonum, registered in Poland by Pfizer Europe MA EEIG. The same ATC class is registered in 2 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Cefoperazone is registered in 2 of 19 countries.
Countries holding a registration under ATC J01DD12 (cefoperazone), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 2 of them publish a price we can compare per daily dose
Cefoperazone · ATC J01DD12
2 / 19 countries
- Czechiaprice
- Polandprice
The record
At a glance
URPL (Poland)- Active substance
- Cefoperazonum
- Manufacturer
- Pfizer Europe MA EEIG
- Country
- Poland (PL)
- ATC code
- J01DD12
- ATC class
- Cefoperazone
- Defined daily dose
- 4 g, P
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- August 23, 2026
Packs & prices · 1
- gtin05909990065011
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
25 interactions on record for cefoperazone.
Graded by severity as the source publishes them — 25 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefoperazone · interactions on record
25 records
- 25 moderate
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefoperazone in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Bulgaria · Медоцеф
- Cyprus · Medocef, Syntocef
- Czechia · Acefa
- Romania · Cefozon, Medocef
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/467da800-4879-48e9-adf7-bd18772b2090 GET /v1/drugs/467da800-4879-48e9-adf7-bd18772b2090?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Proszek do sporządzania roztworu do wstrzykiwań i infuzji",
"source": "urpl",
"strength": "1 g",
"packaging": "05909990065011 ¦ Lz ¦ 2362\n1 fiol.",
"substance": "Cefoperazonum 1 g",
"common_name": "Cefoperazonum",
"pl_product_id": "100013399",
"pozwolenie_nr": "00650",
"auth_procedure": "NAR",
"authorisation_validity": "2023-08-24"
}See everything about cefoperazone.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.